Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment.
Visser
P J
PJ
Department of Psychiatry, University of Maastricht, Maastricht, The Netherlands. pj.visser@np.unimaas.nl
D000544:Alzheimer Disease / Q000175:diagnosis*; D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic / Q000379:methods; D003072:Cognition Disorders / Q000175:diagnosis; D006801:Humans; D018579:Patient Selection; D012107:Research Design
D015415:Biomarkers